Accelerate your process development with platforms by leveraging informational sciences to compound and use process characterization data. The first session focuses on this concept with strategy from NASA's Jet Propulsion Laboratory, plus industry case studies and an audience interactive panel discussion to ask your questions to the experts. Understand the latest tools for implementing quality by design. Hone your scale-down skills in the session on use of scale down models throughout the product lifecycle, with six detailed case studies.

• Knowledge Management Strategies to Leverage and Exploit Process Data to Accelerate Process Development
• Regulatory Updates including Tools for Implementation of Quality by Design
• Advances in Process Models to Enable Improved Scale-Up and Technology Transfer

Advisory Board

• Jeffrey C. Baker, Ph.D., Senior Research Advisor, Manufacturing Sciences and Technology, Eli Lilly and Co.
• Roger A. Hart, Ph.D., Scientific Director, Process Development, Amgen Inc.
• Maninder Hora, Ph.D., Vice President, Process Development, PDL BioPharma, Inc.
• Günter Jagschies, Ph.D., Director R&D, Customer Applications, Protein Separation, GE Healthcare Bio-Sciences, Sweden
• Ellen L. McCormick, Director, BioProcess R&D, Pfizer Global Biologics, Pfizer Inc
• R. Andrew Ramelmeier, Ph.D., Vice President, Manufacturing and Process Development, BioMarin Pharmaceutical, Inc.
• Thomas C. Ransohoff, Vice President and Senior Consultant, BioProcess Technology Consultants, Inc.
• David H. Reifsnyder, Ph.D., Principal Scientist, Process Development-Late Stage Purification, Genentech, Inc.
• Abhinav Shukla, Ph.D., Associate Director, Manufacturing Sciences, Bristol-Myers Squibb Company

View the Agenda

• Day One - Morning
• Day One - Afternoon
• Day Two - Morning
• Day Two - Afternoon
• Day Three

View the Other Tracks

• Production & Economics of Biopharmaceuticals
• Cell Culture & Upstream Processing
• Recovery & Purification